Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesAnalysis of stage IVB endometrial carcinoma patients with distant metastasis: a review of prognoses in 55 patients
International Journal of Clinical Oncology, 08/27/09
Numazaki R et al. – For operable patients, surgery as an initial treatment and reduction of the residual tumor size to less than 2 cm appeared to contribute to a better prognosis. In addition, conservative initial treatment and the presence of non–lung hematogenous metastasis were poor prognostic factors.
Related Articles
Local Biosynthesis of Estrogen in Human Endometrial Carcinoma through Tumor-Stromal Cell Interactions
Clinical Cancer Research, 10/06/09
Relevance Score: 70%
Endometrial Cancer
American Family Physician, 11/12/09
Relevance Score: 68%
p53 overexpression in morphologically ambiguous endometrial carcinomas correlates with adverse clinical outcomes
Modern Pathology, 10/28/09
Relevance Score: 68%
Prognostic markers for coexistent carcinoma in high-risk endometrial hyperplasia with negative D-score: significance of morphometry, hormone receptors and apoptosis for outcome prediction
Acta Obstetricia et Gynecologica Scandinavica, 10/09/09
Relevance Score: 67%
Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting
American Journal of Obstetrics and Gynecology, 10/08/09
Relevance Score: 67%
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
BMC Cancer, 12/20/09
Epithelial-to-Mesenchymal Transition and Ovarian Tumor Progression Induced by Tissue Transglutaminase
Cancer Research, 12/20/09
Adult-Type Granulosa Cell Tumors and FOXL2 Mutation
Cancer Research, 12/20/09
Sponsor
Article Search
Sponsor
Sponsor